nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—PDE3A—penis—prostate cancer	0.0583	0.281	CbGeAlD
Papaverine—PDE10A—prostate gland—prostate cancer	0.0245	0.118	CbGeAlD
Papaverine—PDE3B—prostate gland—prostate cancer	0.0228	0.11	CbGeAlD
Papaverine—PDE3A—prostate gland—prostate cancer	0.0139	0.0672	CbGeAlD
Papaverine—PDE3B—bone marrow—prostate cancer	0.0118	0.0567	CbGeAlD
Papaverine—PDE10A—testis—prostate cancer	0.0108	0.052	CbGeAlD
Papaverine—Blood pressure increased—Estrone—prostate cancer	0.0102	0.0259	CcSEcCtD
Papaverine—PDE3B—testis—prostate cancer	0.01	0.0484	CbGeAlD
Papaverine—PDE4B—prostate gland—prostate cancer	0.01	0.0484	CbGeAlD
Papaverine—Blood pressure increased—Estradiol valerate/Dienogest—prostate cancer	0.00887	0.0226	CcSEcCtD
Papaverine—PDE10A—lymph node—prostate cancer	0.00782	0.0377	CbGeAlD
Papaverine—PDE3B—lymph node—prostate cancer	0.00728	0.0351	CbGeAlD
Papaverine—PDE4B—urethra—prostate cancer	0.00673	0.0324	CbGeAlD
Papaverine—Abdominal discomfort—Estramustine—prostate cancer	0.0064	0.0163	CcSEcCtD
Papaverine—PDE3A—testis—prostate cancer	0.00614	0.0296	CbGeAlD
Papaverine—Blood pressure increased—Ethinyl Estradiol—prostate cancer	0.00576	0.0147	CcSEcCtD
Papaverine—PDE4B—bone marrow—prostate cancer	0.00518	0.025	CbGeAlD
Papaverine—Abdominal discomfort—Degarelix—prostate cancer	0.00507	0.0129	CcSEcCtD
Papaverine—Flushing—Estramustine—prostate cancer	0.00496	0.0126	CcSEcCtD
Papaverine—Trimethoprim—TYMS—prostate cancer	0.00495	0.287	CrCbGaD
Papaverine—Hepatitis—Flutamide—prostate cancer	0.00472	0.012	CcSEcCtD
Papaverine—Blood pressure increased—Conjugated Estrogens—prostate cancer	0.00469	0.012	CcSEcCtD
Papaverine—PDE3A—lymph node—prostate cancer	0.00445	0.0215	CbGeAlD
Papaverine—PDE4B—testis—prostate cancer	0.00443	0.0213	CbGeAlD
Papaverine—Ill-defined disorder—Nilutamide—prostate cancer	0.00383	0.00975	CcSEcCtD
Papaverine—Ill-defined disorder—Flutamide—prostate cancer	0.00381	0.0097	CcSEcCtD
Papaverine—Discomfort—Abiraterone—prostate cancer	0.0038	0.00967	CcSEcCtD
Papaverine—Blood pressure increased—Estradiol—prostate cancer	0.00376	0.00957	CcSEcCtD
Papaverine—Malaise—Nilutamide—prostate cancer	0.00372	0.00947	CcSEcCtD
Papaverine—Malaise—Flutamide—prostate cancer	0.0037	0.00943	CcSEcCtD
Papaverine—Flushing—Cabazitaxel—prostate cancer	0.0037	0.00942	CcSEcCtD
Papaverine—Anorexia—Estramustine—prostate cancer	0.00362	0.00921	CcSEcCtD
Papaverine—Discomfort—Nilutamide—prostate cancer	0.00347	0.00884	CcSEcCtD
Papaverine—Discomfort—Flutamide—prostate cancer	0.00345	0.0088	CcSEcCtD
Papaverine—Ill-defined disorder—Degarelix—prostate cancer	0.00342	0.00871	CcSEcCtD
Papaverine—Malaise—Degarelix—prostate cancer	0.00332	0.00846	CcSEcCtD
Papaverine—Decreased appetite—Estramustine—prostate cancer	0.0033	0.0084	CcSEcCtD
Papaverine—Ill-defined disorder—Cabazitaxel—prostate cancer	0.00322	0.0082	CcSEcCtD
Papaverine—Anorexia—Nilutamide—prostate cancer	0.00321	0.00817	CcSEcCtD
Papaverine—PDE4B—lymph node—prostate cancer	0.00321	0.0155	CbGeAlD
Papaverine—Anorexia—Flutamide—prostate cancer	0.00319	0.00814	CcSEcCtD
Papaverine—Constipation—Abiraterone—prostate cancer	0.00315	0.00802	CcSEcCtD
Papaverine—Malaise—Cabazitaxel—prostate cancer	0.00313	0.00797	CcSEcCtD
Papaverine—Vertigo—Cabazitaxel—prostate cancer	0.00312	0.00794	CcSEcCtD
Papaverine—Discomfort—Degarelix—prostate cancer	0.0031	0.00789	CcSEcCtD
Papaverine—Decreased appetite—Nilutamide—prostate cancer	0.00293	0.00745	CcSEcCtD
Papaverine—Discomfort—Cabazitaxel—prostate cancer	0.00292	0.00744	CcSEcCtD
Papaverine—Decreased appetite—Flutamide—prostate cancer	0.00291	0.00742	CcSEcCtD
Papaverine—Constipation—Nilutamide—prostate cancer	0.00288	0.00733	CcSEcCtD
Papaverine—Constipation—Flutamide—prostate cancer	0.00287	0.0073	CcSEcCtD
Papaverine—Abdominal discomfort—Conjugated Estrogens—prostate cancer	0.00282	0.00719	CcSEcCtD
Papaverine—Feeling abnormal—Nilutamide—prostate cancer	0.00277	0.00706	CcSEcCtD
Papaverine—Feeling abnormal—Flutamide—prostate cancer	0.00276	0.00703	CcSEcCtD
Papaverine—Anorexia—Cabazitaxel—prostate cancer	0.0027	0.00688	CcSEcCtD
Papaverine—Decreased appetite—Degarelix—prostate cancer	0.00261	0.00666	CcSEcCtD
Papaverine—Diarrhoea—Estramustine—prostate cancer	0.0026	0.00661	CcSEcCtD
Papaverine—Constipation—Degarelix—prostate cancer	0.00257	0.00655	CcSEcCtD
Papaverine—Diarrhoea—Abiraterone—prostate cancer	0.00252	0.00642	CcSEcCtD
Papaverine—Feeling abnormal—Degarelix—prostate cancer	0.00248	0.00631	CcSEcCtD
Papaverine—Decreased appetite—Cabazitaxel—prostate cancer	0.00246	0.00627	CcSEcCtD
Papaverine—Constipation—Cabazitaxel—prostate cancer	0.00242	0.00617	CcSEcCtD
Papaverine—Blood pressure increased—Docetaxel—prostate cancer	0.00242	0.00616	CcSEcCtD
Papaverine—Rash—Estramustine—prostate cancer	0.00239	0.00609	CcSEcCtD
Papaverine—Dermatitis—Estramustine—prostate cancer	0.00239	0.00609	CcSEcCtD
Papaverine—Hepatitis—Goserelin—prostate cancer	0.00238	0.00606	CcSEcCtD
Papaverine—Headache—Estramustine—prostate cancer	0.00238	0.00605	CcSEcCtD
Papaverine—Blood pressure increased—Capecitabine—prostate cancer	0.00234	0.00597	CcSEcCtD
Papaverine—Ill-defined disorder—Ethinyl Estradiol—prostate cancer	0.00234	0.00595	CcSEcCtD
Papaverine—Feeling abnormal—Cabazitaxel—prostate cancer	0.00233	0.00595	CcSEcCtD
Papaverine—Rash—Abiraterone—prostate cancer	0.00232	0.00592	CcSEcCtD
Papaverine—Dermatitis—Abiraterone—prostate cancer	0.00232	0.00591	CcSEcCtD
Papaverine—Anorexia—Bicalutamide—prostate cancer	0.00232	0.0059	CcSEcCtD
Papaverine—Diarrhoea—Nilutamide—prostate cancer	0.0023	0.00587	CcSEcCtD
Papaverine—Diarrhoea—Flutamide—prostate cancer	0.00229	0.00584	CcSEcCtD
Papaverine—Rash—Estrone—prostate cancer	0.00229	0.00582	CcSEcCtD
Papaverine—Dermatitis—Estrone—prostate cancer	0.00228	0.00581	CcSEcCtD
Papaverine—Headache—Estrone—prostate cancer	0.00227	0.00578	CcSEcCtD
Papaverine—Malaise—Ethinyl Estradiol—prostate cancer	0.00227	0.00578	CcSEcCtD
Papaverine—Abdominal discomfort—Estradiol—prostate cancer	0.00226	0.00575	CcSEcCtD
Papaverine—Nausea—Estramustine—prostate cancer	0.00225	0.00574	CcSEcCtD
Papaverine—Verapamil—CYP2C18—prostate cancer	0.00218	0.127	CrCbGaD
Papaverine—Bevantolol—ADRB2—prostate cancer	0.00216	0.125	CrCbGaD
Papaverine—Nausea—Estrone—prostate cancer	0.00215	0.00548	CcSEcCtD
Papaverine—Rash—Nilutamide—prostate cancer	0.00212	0.00541	CcSEcCtD
Papaverine—Dermatitis—Nilutamide—prostate cancer	0.00212	0.0054	CcSEcCtD
Papaverine—Discomfort—Ethinyl Estradiol—prostate cancer	0.00212	0.00539	CcSEcCtD
Papaverine—Rash—Flutamide—prostate cancer	0.00211	0.00538	CcSEcCtD
Papaverine—Decreased appetite—Bicalutamide—prostate cancer	0.00211	0.00538	CcSEcCtD
Papaverine—Dermatitis—Flutamide—prostate cancer	0.00211	0.00538	CcSEcCtD
Papaverine—Headache—Nilutamide—prostate cancer	0.00211	0.00537	CcSEcCtD
Papaverine—Headache—Flutamide—prostate cancer	0.0021	0.00535	CcSEcCtD
Papaverine—Constipation—Bicalutamide—prostate cancer	0.00208	0.00529	CcSEcCtD
Papaverine—Diarrhoea—Degarelix—prostate cancer	0.00206	0.00524	CcSEcCtD
Papaverine—Feeling abnormal—Bicalutamide—prostate cancer	0.002	0.0051	CcSEcCtD
Papaverine—Nausea—Nilutamide—prostate cancer	0.002	0.00509	CcSEcCtD
Papaverine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00199	0.00508	CcSEcCtD
Papaverine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00199	0.00507	CcSEcCtD
Papaverine—Nausea—Flutamide—prostate cancer	0.00199	0.00507	CcSEcCtD
Papaverine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00198	0.00505	CcSEcCtD
Papaverine—Diarrhoea—Cabazitaxel—prostate cancer	0.00194	0.00494	CcSEcCtD
Papaverine—Ill-defined disorder—Goserelin—prostate cancer	0.00192	0.00489	CcSEcCtD
Papaverine—Rash—Degarelix—prostate cancer	0.0019	0.00483	CcSEcCtD
Papaverine—Dermatitis—Degarelix—prostate cancer	0.00189	0.00482	CcSEcCtD
Papaverine—Hepatitis—Estradiol—prostate cancer	0.00189	0.0048	CcSEcCtD
Papaverine—Headache—Degarelix—prostate cancer	0.00188	0.0048	CcSEcCtD
Papaverine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00188	0.00478	CcSEcCtD
Papaverine—Malaise—Goserelin—prostate cancer	0.00187	0.00476	CcSEcCtD
Papaverine—Vertigo—Conjugated Estrogens—prostate cancer	0.00184	0.00469	CcSEcCtD
Papaverine—Nausea—Degarelix—prostate cancer	0.00179	0.00455	CcSEcCtD
Papaverine—Verapamil—SLC22A1—prostate cancer	0.00178	0.103	CrCbGaD
Papaverine—Headache—Cabazitaxel—prostate cancer	0.00177	0.00452	CcSEcCtD
Papaverine—Hepatitis—Mitoxantrone—prostate cancer	0.00176	0.00448	CcSEcCtD
Papaverine—Constipation—Ethinyl Estradiol—prostate cancer	0.00176	0.00447	CcSEcCtD
Papaverine—Flushing—Estradiol—prostate cancer	0.00175	0.00446	CcSEcCtD
Papaverine—Discomfort—Goserelin—prostate cancer	0.00174	0.00444	CcSEcCtD
Papaverine—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.00169	0.00431	CcSEcCtD
Papaverine—Nausea—Cabazitaxel—prostate cancer	0.00168	0.00429	CcSEcCtD
Papaverine—Diarrhoea—Bicalutamide—prostate cancer	0.00166	0.00423	CcSEcCtD
Papaverine—Tofisopam—CYP3A4—prostate cancer	0.00162	0.094	CrCbGaD
Papaverine—Anorexia—Goserelin—prostate cancer	0.00161	0.0041	CcSEcCtD
Papaverine—Anorexia—Conjugated Estrogens—prostate cancer	0.0016	0.00407	CcSEcCtD
Papaverine—Rash—Bicalutamide—prostate cancer	0.00153	0.0039	CcSEcCtD
Papaverine—Dermatitis—Bicalutamide—prostate cancer	0.00153	0.0039	CcSEcCtD
Papaverine—Ill-defined disorder—Estradiol—prostate cancer	0.00152	0.00388	CcSEcCtD
Papaverine—Headache—Bicalutamide—prostate cancer	0.00152	0.00388	CcSEcCtD
Papaverine—Trimethoprim—CYP3A4—prostate cancer	0.00151	0.0874	CrCbGaD
Papaverine—Malaise—Estradiol—prostate cancer	0.00148	0.00377	CcSEcCtD
Papaverine—Vertigo—Estradiol—prostate cancer	0.00148	0.00376	CcSEcCtD
Papaverine—Decreased appetite—Goserelin—prostate cancer	0.00147	0.00374	CcSEcCtD
Papaverine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.00146	0.00371	CcSEcCtD
Papaverine—Constipation—Goserelin—prostate cancer	0.00145	0.00368	CcSEcCtD
Papaverine—Nausea—Bicalutamide—prostate cancer	0.00144	0.00368	CcSEcCtD
Papaverine—Verapamil—CYP3A5—prostate cancer	0.00144	0.0834	CrCbGaD
Papaverine—Constipation—Conjugated Estrogens—prostate cancer	0.00143	0.00365	CcSEcCtD
Papaverine—Ill-defined disorder—Mitoxantrone—prostate cancer	0.00142	0.00362	CcSEcCtD
Papaverine—Abdominal discomfort—Capecitabine—prostate cancer	0.00141	0.00359	CcSEcCtD
Papaverine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00141	0.00358	CcSEcCtD
Papaverine—Feeling abnormal—Goserelin—prostate cancer	0.00139	0.00355	CcSEcCtD
Papaverine—Discomfort—Estradiol—prostate cancer	0.00138	0.00352	CcSEcCtD
Papaverine—Malaise—Mitoxantrone—prostate cancer	0.00138	0.00351	CcSEcCtD
Papaverine—Flushing—Etoposide—prostate cancer	0.00136	0.00346	CcSEcCtD
Papaverine—Rash—Ethinyl Estradiol—prostate cancer	0.0013	0.0033	CcSEcCtD
Papaverine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00129	0.0033	CcSEcCtD
Papaverine—Discomfort—Mitoxantrone—prostate cancer	0.00129	0.00328	CcSEcCtD
Papaverine—Headache—Ethinyl Estradiol—prostate cancer	0.00129	0.00328	CcSEcCtD
Papaverine—Nausea—Ethinyl Estradiol—prostate cancer	0.00122	0.00311	CcSEcCtD
Papaverine—Hepatitis—Docetaxel—prostate cancer	0.00122	0.00309	CcSEcCtD
Papaverine—Anorexia—Mitoxantrone—prostate cancer	0.00119	0.00303	CcSEcCtD
Papaverine—Ill-defined disorder—Etoposide—prostate cancer	0.00118	0.00301	CcSEcCtD
Papaverine—Hepatitis—Capecitabine—prostate cancer	0.00118	0.003	CcSEcCtD
Papaverine—Decreased appetite—Estradiol—prostate cancer	0.00117	0.00297	CcSEcCtD
Papaverine—Diarrhoea—Goserelin—prostate cancer	0.00116	0.00295	CcSEcCtD
Papaverine—Malaise—Etoposide—prostate cancer	0.00115	0.00292	CcSEcCtD
Papaverine—Constipation—Estradiol—prostate cancer	0.00115	0.00292	CcSEcCtD
Papaverine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00115	0.00292	CcSEcCtD
Papaverine—Vertigo—Etoposide—prostate cancer	0.00114	0.00291	CcSEcCtD
Papaverine—Flushing—Docetaxel—prostate cancer	0.00113	0.00287	CcSEcCtD
Papaverine—Feeling abnormal—Estradiol—prostate cancer	0.0011	0.00281	CcSEcCtD
Papaverine—Flushing—Capecitabine—prostate cancer	0.00109	0.00278	CcSEcCtD
Papaverine—Decreased appetite—Mitoxantrone—prostate cancer	0.00109	0.00276	CcSEcCtD
Papaverine—Discomfort—Etoposide—prostate cancer	0.00107	0.00273	CcSEcCtD
Papaverine—Constipation—Mitoxantrone—prostate cancer	0.00107	0.00272	CcSEcCtD
Papaverine—Rash—Goserelin—prostate cancer	0.00107	0.00271	CcSEcCtD
Papaverine—Dermatitis—Goserelin—prostate cancer	0.00106	0.00271	CcSEcCtD
Papaverine—Headache—Goserelin—prostate cancer	0.00106	0.0027	CcSEcCtD
Papaverine—Rash—Conjugated Estrogens—prostate cancer	0.00106	0.00269	CcSEcCtD
Papaverine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00105	0.00269	CcSEcCtD
Papaverine—Headache—Conjugated Estrogens—prostate cancer	0.00105	0.00267	CcSEcCtD
Papaverine—Feeling abnormal—Mitoxantrone—prostate cancer	0.00103	0.00262	CcSEcCtD
Papaverine—Nausea—Goserelin—prostate cancer	0.001	0.00256	CcSEcCtD
Papaverine—Nausea—Conjugated Estrogens—prostate cancer	0.000995	0.00253	CcSEcCtD
Papaverine—Anorexia—Etoposide—prostate cancer	0.00099	0.00252	CcSEcCtD
Papaverine—Verapamil—CYP2C19—prostate cancer	0.000979	0.0568	CrCbGaD
Papaverine—Flushing—Prednisone—prostate cancer	0.000972	0.00248	CcSEcCtD
Papaverine—Ill-defined disorder—Capecitabine—prostate cancer	0.00095	0.00242	CcSEcCtD
Papaverine—Malaise—Capecitabine—prostate cancer	0.000923	0.00235	CcSEcCtD
Papaverine—Vertigo—Capecitabine—prostate cancer	0.00092	0.00234	CcSEcCtD
Papaverine—Diarrhoea—Estradiol—prostate cancer	0.000917	0.00234	CcSEcCtD
Papaverine—Decreased appetite—Etoposide—prostate cancer	0.000903	0.0023	CcSEcCtD
Papaverine—Constipation—Etoposide—prostate cancer	0.000888	0.00226	CcSEcCtD
Papaverine—Discomfort—Capecitabine—prostate cancer	0.000861	0.00219	CcSEcCtD
Papaverine—Feeling abnormal—Etoposide—prostate cancer	0.000856	0.00218	CcSEcCtD
Papaverine—Diarrhoea—Mitoxantrone—prostate cancer	0.000854	0.00218	CcSEcCtD
Papaverine—Ill-defined disorder—Prednisone—prostate cancer	0.000846	0.00216	CcSEcCtD
Papaverine—Rash—Estradiol—prostate cancer	0.000845	0.00215	CcSEcCtD
Papaverine—Dermatitis—Estradiol—prostate cancer	0.000844	0.00215	CcSEcCtD
Papaverine—Headache—Estradiol—prostate cancer	0.00084	0.00214	CcSEcCtD
Papaverine—Anorexia—Docetaxel—prostate cancer	0.000823	0.0021	CcSEcCtD
Papaverine—Malaise—Prednisone—prostate cancer	0.000823	0.00209	CcSEcCtD
Papaverine—Vertigo—Prednisone—prostate cancer	0.00082	0.00209	CcSEcCtD
Papaverine—Hepatitis—Epirubicin—prostate cancer	0.00082	0.00209	CcSEcCtD
Papaverine—Anorexia—Capecitabine—prostate cancer	0.000797	0.00203	CcSEcCtD
Papaverine—Nausea—Estradiol—prostate cancer	0.000796	0.00203	CcSEcCtD
Papaverine—Rash—Mitoxantrone—prostate cancer	0.000787	0.00201	CcSEcCtD
Papaverine—Dermatitis—Mitoxantrone—prostate cancer	0.000787	0.002	CcSEcCtD
Papaverine—Headache—Mitoxantrone—prostate cancer	0.000782	0.00199	CcSEcCtD
Papaverine—Discomfort—Prednisone—prostate cancer	0.000767	0.00195	CcSEcCtD
Papaverine—Flushing—Epirubicin—prostate cancer	0.000761	0.00194	CcSEcCtD
Papaverine—Hepatitis—Doxorubicin—prostate cancer	0.000758	0.00193	CcSEcCtD
Papaverine—Decreased appetite—Docetaxel—prostate cancer	0.00075	0.00191	CcSEcCtD
Papaverine—Nausea—Mitoxantrone—prostate cancer	0.000742	0.00189	CcSEcCtD
Papaverine—Constipation—Docetaxel—prostate cancer	0.000738	0.00188	CcSEcCtD
Papaverine—Decreased appetite—Capecitabine—prostate cancer	0.000727	0.00185	CcSEcCtD
Papaverine—Constipation—Capecitabine—prostate cancer	0.000715	0.00182	CcSEcCtD
Papaverine—Feeling abnormal—Docetaxel—prostate cancer	0.000711	0.00181	CcSEcCtD
Papaverine—Diarrhoea—Etoposide—prostate cancer	0.000711	0.00181	CcSEcCtD
Papaverine—Anorexia—Prednisone—prostate cancer	0.00071	0.00181	CcSEcCtD
Papaverine—Flushing—Doxorubicin—prostate cancer	0.000704	0.00179	CcSEcCtD
Papaverine—Feeling abnormal—Capecitabine—prostate cancer	0.000689	0.00175	CcSEcCtD
Papaverine—Ill-defined disorder—Epirubicin—prostate cancer	0.000662	0.00169	CcSEcCtD
Papaverine—Rash—Etoposide—prostate cancer	0.000655	0.00167	CcSEcCtD
Papaverine—Dermatitis—Etoposide—prostate cancer	0.000654	0.00167	CcSEcCtD
Papaverine—Headache—Etoposide—prostate cancer	0.000651	0.00166	CcSEcCtD
Papaverine—Decreased appetite—Prednisone—prostate cancer	0.000647	0.00165	CcSEcCtD
Papaverine—Malaise—Epirubicin—prostate cancer	0.000643	0.00164	CcSEcCtD
Papaverine—Vertigo—Epirubicin—prostate cancer	0.000641	0.00163	CcSEcCtD
Papaverine—Constipation—Prednisone—prostate cancer	0.000637	0.00162	CcSEcCtD
Papaverine—Verapamil—CYP3A4—prostate cancer	0.000623	0.0361	CrCbGaD
Papaverine—Nausea—Etoposide—prostate cancer	0.000617	0.00157	CcSEcCtD
Papaverine—Feeling abnormal—Prednisone—prostate cancer	0.000613	0.00156	CcSEcCtD
Papaverine—Ill-defined disorder—Doxorubicin—prostate cancer	0.000612	0.00156	CcSEcCtD
Papaverine—Discomfort—Epirubicin—prostate cancer	0.0006	0.00153	CcSEcCtD
Papaverine—Malaise—Doxorubicin—prostate cancer	0.000595	0.00152	CcSEcCtD
Papaverine—Vertigo—Doxorubicin—prostate cancer	0.000593	0.00151	CcSEcCtD
Papaverine—Diarrhoea—Docetaxel—prostate cancer	0.000591	0.0015	CcSEcCtD
Papaverine—Diarrhoea—Capecitabine—prostate cancer	0.000572	0.00146	CcSEcCtD
Papaverine—Discomfort—Doxorubicin—prostate cancer	0.000555	0.00141	CcSEcCtD
Papaverine—Anorexia—Epirubicin—prostate cancer	0.000555	0.00141	CcSEcCtD
Papaverine—Rash—Docetaxel—prostate cancer	0.000544	0.00139	CcSEcCtD
Papaverine—Dermatitis—Docetaxel—prostate cancer	0.000544	0.00138	CcSEcCtD
Papaverine—Headache—Docetaxel—prostate cancer	0.000541	0.00138	CcSEcCtD
Papaverine—Rash—Capecitabine—prostate cancer	0.000527	0.00134	CcSEcCtD
Papaverine—Dermatitis—Capecitabine—prostate cancer	0.000526	0.00134	CcSEcCtD
Papaverine—Headache—Capecitabine—prostate cancer	0.000524	0.00133	CcSEcCtD
Papaverine—Anorexia—Doxorubicin—prostate cancer	0.000514	0.00131	CcSEcCtD
Papaverine—Nausea—Docetaxel—prostate cancer	0.000513	0.00131	CcSEcCtD
Papaverine—Diarrhoea—Prednisone—prostate cancer	0.000509	0.0013	CcSEcCtD
Papaverine—Decreased appetite—Epirubicin—prostate cancer	0.000506	0.00129	CcSEcCtD
Papaverine—Constipation—Epirubicin—prostate cancer	0.000498	0.00127	CcSEcCtD
Papaverine—Nausea—Capecitabine—prostate cancer	0.000496	0.00126	CcSEcCtD
Papaverine—Feeling abnormal—Epirubicin—prostate cancer	0.00048	0.00122	CcSEcCtD
Papaverine—Rash—Prednisone—prostate cancer	0.000469	0.0012	CcSEcCtD
Papaverine—Dermatitis—Prednisone—prostate cancer	0.000469	0.00119	CcSEcCtD
Papaverine—Decreased appetite—Doxorubicin—prostate cancer	0.000468	0.00119	CcSEcCtD
Papaverine—Headache—Prednisone—prostate cancer	0.000466	0.00119	CcSEcCtD
Papaverine—Constipation—Doxorubicin—prostate cancer	0.000461	0.00117	CcSEcCtD
Papaverine—Feeling abnormal—Doxorubicin—prostate cancer	0.000444	0.00113	CcSEcCtD
Papaverine—Nausea—Prednisone—prostate cancer	0.000442	0.00113	CcSEcCtD
Papaverine—Diarrhoea—Epirubicin—prostate cancer	0.000398	0.00101	CcSEcCtD
Papaverine—Diarrhoea—Doxorubicin—prostate cancer	0.000369	0.000939	CcSEcCtD
Papaverine—Rash—Epirubicin—prostate cancer	0.000367	0.000935	CcSEcCtD
Papaverine—Dermatitis—Epirubicin—prostate cancer	0.000367	0.000934	CcSEcCtD
Papaverine—Headache—Epirubicin—prostate cancer	0.000365	0.000929	CcSEcCtD
Papaverine—Nausea—Epirubicin—prostate cancer	0.000346	0.000881	CcSEcCtD
Papaverine—Rash—Doxorubicin—prostate cancer	0.00034	0.000865	CcSEcCtD
Papaverine—Dermatitis—Doxorubicin—prostate cancer	0.000339	0.000864	CcSEcCtD
Papaverine—Headache—Doxorubicin—prostate cancer	0.000337	0.00086	CcSEcCtD
Papaverine—Nausea—Doxorubicin—prostate cancer	0.00032	0.000815	CcSEcCtD
Papaverine—PDE3B—Hemostasis—PIK3CA—prostate cancer	8.29e-05	0.000217	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—CXCL8—prostate cancer	8.25e-05	0.000216	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—JAK2—prostate cancer	8.24e-05	0.000215	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MAP2K1—prostate cancer	8.22e-05	0.000215	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—KRAS—prostate cancer	8.21e-05	0.000215	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—JAK2—prostate cancer	8.21e-05	0.000215	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—MAP2K1—prostate cancer	8.2e-05	0.000214	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CD—prostate cancer	8.17e-05	0.000213	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CD—prostate cancer	8.15e-05	0.000213	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—VAV3—prostate cancer	8.14e-05	0.000213	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—PIK3CA—prostate cancer	8.09e-05	0.000211	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SERPINE1—prostate cancer	8.08e-05	0.000211	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGF10—prostate cancer	8.03e-05	0.00021	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TGFBR2—prostate cancer	8.03e-05	0.00021	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—TP53—prostate cancer	8.02e-05	0.000209	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—KRAS—prostate cancer	8e-05	0.000209	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—LPL—prostate cancer	7.95e-05	0.000208	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ADRB2—prostate cancer	7.94e-05	0.000208	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ITPR1—prostate cancer	7.9e-05	0.000206	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—IL2—prostate cancer	7.89e-05	0.000206	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PDGFRB—prostate cancer	7.88e-05	0.000206	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—JAK2—prostate cancer	7.83e-05	0.000205	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PIK3CB—prostate cancer	7.82e-05	0.000204	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—FGF2—prostate cancer	7.82e-05	0.000204	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—MAP2K1—prostate cancer	7.8e-05	0.000204	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PIK3CB—prostate cancer	7.8e-05	0.000204	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CD—prostate cancer	7.75e-05	0.000203	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—VAV3—prostate cancer	7.74e-05	0.000202	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NOS3—prostate cancer	7.71e-05	0.000202	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ITGB3—prostate cancer	7.68e-05	0.000201	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TGFBR2—prostate cancer	7.63e-05	0.0002	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IGF1R—prostate cancer	7.55e-05	0.000197	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—PIK3CA—prostate cancer	7.55e-05	0.000197	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CXCL8—prostate cancer	7.52e-05	0.000196	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ITPR1—prostate cancer	7.51e-05	0.000196	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—JAK2—prostate cancer	7.5e-05	0.000196	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CXCL8—prostate cancer	7.5e-05	0.000196	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—JAK2—prostate cancer	7.48e-05	0.000195	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ERBB3—prostate cancer	7.45e-05	0.000195	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CB—prostate cancer	7.44e-05	0.000194	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FGFR2—prostate cancer	7.44e-05	0.000194	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PIK3CA—prostate cancer	7.35e-05	0.000192	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MDM2—prostate cancer	7.32e-05	0.000191	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TP53—prostate cancer	7.3e-05	0.000191	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—LPL—prostate cancer	7.24e-05	0.000189	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—ERBB2—prostate cancer	7.22e-05	0.000189	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—IL2—prostate cancer	7.18e-05	0.000188	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF1R—prostate cancer	7.18e-05	0.000188	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PDGFRB—prostate cancer	7.17e-05	0.000188	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL2—prostate cancer	7.16e-05	0.000187	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CXCL8—prostate cancer	7.15e-05	0.000187	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TERT—prostate cancer	7.14e-05	0.000187	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CB—prostate cancer	7.12e-05	0.000186	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—JAK2—prostate cancer	7.11e-05	0.000186	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CB—prostate cancer	7.1e-05	0.000186	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ITGB3—prostate cancer	6.99e-05	0.000183	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—LPL—prostate cancer	6.89e-05	0.00018	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CXCL8—prostate cancer	6.84e-05	0.000179	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—IL2—prostate cancer	6.83e-05	0.000179	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CXCL8—prostate cancer	6.83e-05	0.000178	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HIF1A—prostate cancer	6.83e-05	0.000178	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PDGFRB—prostate cancer	6.82e-05	0.000178	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ERBB3—prostate cancer	6.78e-05	0.000177	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGFR2—prostate cancer	6.77e-05	0.000177	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—AKT1—prostate cancer	6.77e-05	0.000177	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CB—prostate cancer	6.76e-05	0.000177	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN1B—prostate cancer	6.68e-05	0.000175	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—LEP—prostate cancer	6.66e-05	0.000174	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ITGB3—prostate cancer	6.65e-05	0.000174	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—AKT1—prostate cancer	6.61e-05	0.000173	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CAV1—prostate cancer	6.6e-05	0.000173	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CASP3—prostate cancer	6.55e-05	0.000171	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL2—prostate cancer	6.54e-05	0.000171	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KDR—prostate cancer	6.53e-05	0.000171	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL2—prostate cancer	6.52e-05	0.00017	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL6—prostate cancer	6.51e-05	0.00017	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TERT—prostate cancer	6.5e-05	0.00017	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CXCL8—prostate cancer	6.49e-05	0.00017	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ERBB3—prostate cancer	6.45e-05	0.000169	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGFR2—prostate cancer	6.44e-05	0.000168	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCND1—prostate cancer	6.37e-05	0.000167	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ESR1—prostate cancer	6.36e-05	0.000166	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CTNNB1—prostate cancer	6.31e-05	0.000165	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HIF1A—prostate cancer	6.22e-05	0.000162	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—BAD—prostate cancer	6.21e-05	0.000162	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL2—prostate cancer	6.21e-05	0.000162	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MMP9—prostate cancer	6.19e-05	0.000162	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TERT—prostate cancer	6.18e-05	0.000162	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN1A—prostate cancer	6.17e-05	0.000161	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—AKT1—prostate cancer	6.16e-05	0.000161	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTEN—prostate cancer	6.15e-05	0.000161	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—LEP—prostate cancer	6.07e-05	0.000159	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—APC—prostate cancer	6.01e-05	0.000157	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CG—prostate cancer	6.01e-05	0.000157	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CAV1—prostate cancer	6.01e-05	0.000157	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—AKT1—prostate cancer	6e-05	0.000157	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KDR—prostate cancer	5.95e-05	0.000155	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EGF—prostate cancer	5.94e-05	0.000155	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IRS1—prostate cancer	5.94e-05	0.000155	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HIF1A—prostate cancer	5.91e-05	0.000155	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—EP300—prostate cancer	5.87e-05	0.000153	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ESR1—prostate cancer	5.79e-05	0.000151	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—LEP—prostate cancer	5.77e-05	0.000151	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GSK3B—prostate cancer	5.77e-05	0.000151	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CAV1—prostate cancer	5.72e-05	0.000149	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SRC—prostate cancer	5.71e-05	0.000149	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—INS—prostate cancer	5.69e-05	0.000149	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KDR—prostate cancer	5.65e-05	0.000148	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—BAD—prostate cancer	5.65e-05	0.000148	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CREBBP—prostate cancer	5.58e-05	0.000146	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—VEGFA—prostate cancer	5.56e-05	0.000145	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ESR1—prostate cancer	5.51e-05	0.000144	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IGF1—prostate cancer	5.51e-05	0.000144	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—STAT3—prostate cancer	5.5e-05	0.000144	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—EGFR—prostate cancer	5.48e-05	0.000143	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CG—prostate cancer	5.48e-05	0.000143	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—APC—prostate cancer	5.48e-05	0.000143	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EGF—prostate cancer	5.41e-05	0.000141	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IRS1—prostate cancer	5.41e-05	0.000141	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—BAD—prostate cancer	5.38e-05	0.000141	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAP2K1—prostate cancer	5.32e-05	0.000139	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CD—prostate cancer	5.29e-05	0.000138	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GSK3B—prostate cancer	5.26e-05	0.000137	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—PIK3CA—prostate cancer	5.24e-05	0.000137	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SERPINE1—prostate cancer	5.23e-05	0.000137	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CG—prostate cancer	5.21e-05	0.000136	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—APC—prostate cancer	5.21e-05	0.000136	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—INS—prostate cancer	5.18e-05	0.000135	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—KRAS—prostate cancer	5.18e-05	0.000135	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EGF—prostate cancer	5.15e-05	0.000135	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IRS1—prostate cancer	5.15e-05	0.000135	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MYC—prostate cancer	5.11e-05	0.000134	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TGFB1—prostate cancer	5.1e-05	0.000133	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CREBBP—prostate cancer	5.08e-05	0.000133	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FGF2—prostate cancer	5.06e-05	0.000132	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IGF1—prostate cancer	5.01e-05	0.000131	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—EGFR—prostate cancer	5e-05	0.000131	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GSK3B—prostate cancer	5e-05	0.000131	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NOS3—prostate cancer	4.99e-05	0.00013	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—EGFR—prostate cancer	4.99e-05	0.00013	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—INS—prostate cancer	4.93e-05	0.000129	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—JAK2—prostate cancer	4.85e-05	0.000127	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAP2K1—prostate cancer	4.85e-05	0.000127	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CREBBP—prostate cancer	4.83e-05	0.000126	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CD—prostate cancer	4.81e-05	0.000126	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF1—prostate cancer	4.77e-05	0.000125	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PIK3CA—prostate cancer	4.77e-05	0.000125	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SERPINE1—prostate cancer	4.76e-05	0.000124	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PIK3CA—prostate cancer	4.75e-05	0.000124	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—EGFR—prostate cancer	4.75e-05	0.000124	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MDM2—prostate cancer	4.74e-05	0.000124	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—KRAS—prostate cancer	4.72e-05	0.000123	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—KRAS—prostate cancer	4.71e-05	0.000123	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ERBB2—prostate cancer	4.67e-05	0.000122	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGF2—prostate cancer	4.61e-05	0.00012	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAP2K1—prostate cancer	4.61e-05	0.00012	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CB—prostate cancer	4.61e-05	0.00012	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CD—prostate cancer	4.58e-05	0.00012	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NOS3—prostate cancer	4.55e-05	0.000119	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CA—prostate cancer	4.54e-05	0.000119	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SERPINE1—prostate cancer	4.53e-05	0.000118	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—KRAS—prostate cancer	4.48e-05	0.000117	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CXCL8—prostate cancer	4.43e-05	0.000116	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—JAK2—prostate cancer	4.42e-05	0.000115	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGF2—prostate cancer	4.38e-05	0.000115	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CA—prostate cancer	4.34e-05	0.000113	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CA—prostate cancer	4.33e-05	0.000113	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NOS3—prostate cancer	4.32e-05	0.000113	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN1B—prostate cancer	4.32e-05	0.000113	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MDM2—prostate cancer	4.31e-05	0.000113	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—AKT1—prostate cancer	4.28e-05	0.000112	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ERBB2—prostate cancer	4.25e-05	0.000111	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CASP3—prostate cancer	4.24e-05	0.000111	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL2—prostate cancer	4.23e-05	0.000111	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL6—prostate cancer	4.21e-05	0.00011	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—JAK2—prostate cancer	4.2e-05	0.00011	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TP53—prostate cancer	4.2e-05	0.00011	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CB—prostate cancer	4.2e-05	0.00011	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCND1—prostate cancer	4.13e-05	0.000108	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CA—prostate cancer	4.12e-05	0.000108	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MDM2—prostate cancer	4.1e-05	0.000107	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CTNNB1—prostate cancer	4.09e-05	0.000107	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ERBB2—prostate cancer	4.04e-05	0.000106	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CXCL8—prostate cancer	4.03e-05	0.000105	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MMP9—prostate cancer	4e-05	0.000105	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CB—prostate cancer	3.99e-05	0.000104	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN1A—prostate cancer	3.99e-05	0.000104	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTEN—prostate cancer	3.98e-05	0.000104	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN1B—prostate cancer	3.94e-05	0.000103	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—AKT1—prostate cancer	3.9e-05	0.000102	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—AKT1—prostate cancer	3.88e-05	0.000102	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CASP3—prostate cancer	3.86e-05	0.000101	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL2—prostate cancer	3.85e-05	0.000101	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL6—prostate cancer	3.84e-05	0.0001	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CXCL8—prostate cancer	3.84e-05	0.0001	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL6—prostate cancer	3.83e-05	0.0001	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EP300—prostate cancer	3.8e-05	9.92e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCND1—prostate cancer	3.76e-05	9.82e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN1B—prostate cancer	3.75e-05	9.79e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CTNNB1—prostate cancer	3.72e-05	9.72e-05	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AKT1—prostate cancer	3.71e-05	9.68e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SRC—prostate cancer	3.69e-05	9.65e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CASP3—prostate cancer	3.67e-05	9.59e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL2—prostate cancer	3.67e-05	9.58e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MMP9—prostate cancer	3.65e-05	9.53e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL6—prostate cancer	3.65e-05	9.53e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN1A—prostate cancer	3.63e-05	9.5e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTEN—prostate cancer	3.63e-05	9.48e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—VEGFA—prostate cancer	3.6e-05	9.4e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCND1—prostate cancer	3.57e-05	9.34e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—STAT3—prostate cancer	3.56e-05	9.31e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKT1—prostate cancer	3.55e-05	9.27e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CTNNB1—prostate cancer	3.54e-05	9.25e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AKT1—prostate cancer	3.54e-05	9.25e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MMP9—prostate cancer	3.47e-05	9.07e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EP300—prostate cancer	3.46e-05	9.04e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN1A—prostate cancer	3.46e-05	9.03e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTEN—prostate cancer	3.45e-05	9.01e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AKT1—prostate cancer	3.36e-05	8.79e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SRC—prostate cancer	3.36e-05	8.79e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MYC—prostate cancer	3.31e-05	8.65e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TGFB1—prostate cancer	3.3e-05	8.63e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EP300—prostate cancer	3.29e-05	8.6e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—VEGFA—prostate cancer	3.28e-05	8.56e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—STAT3—prostate cancer	3.24e-05	8.48e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EGFR—prostate cancer	3.24e-05	8.46e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SRC—prostate cancer	3.2e-05	8.36e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—VEGFA—prostate cancer	3.12e-05	8.14e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—STAT3—prostate cancer	3.08e-05	8.06e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KRAS—prostate cancer	3.06e-05	7.99e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MYC—prostate cancer	3.01e-05	7.88e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TGFB1—prostate cancer	3.01e-05	7.86e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EGFR—prostate cancer	2.95e-05	7.7e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MYC—prostate cancer	2.87e-05	7.49e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TGFB1—prostate cancer	2.86e-05	7.47e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CA—prostate cancer	2.81e-05	7.34e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EGFR—prostate cancer	2.8e-05	7.33e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KRAS—prostate cancer	2.78e-05	7.28e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TP53—prostate cancer	2.72e-05	7.1e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KRAS—prostate cancer	2.65e-05	6.92e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CA—prostate cancer	2.56e-05	6.69e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6—prostate cancer	2.49e-05	6.5e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TP53—prostate cancer	2.47e-05	6.47e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CA—prostate cancer	2.43e-05	6.36e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TP53—prostate cancer	2.35e-05	6.15e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT1—prostate cancer	2.29e-05	6e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6—prostate cancer	2.27e-05	5.92e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6—prostate cancer	2.15e-05	5.63e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT1—prostate cancer	2.09e-05	5.46e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT1—prostate cancer	1.99e-05	5.19e-05	CbGpPWpGaD
